Yurista, S. R., Silljé, H. H. W., Rienstra, M., de Boer, R. A., & Westenbrink, B. D. (2020). Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? Cardiovasc Diabetol.
シカゴスタイル引用形Yurista, Salva R., Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, , B. Daan Westenbrink. "Sodium-glucose Co-transporter 2 Inhibition As a Mitochondrial Therapy for Atrial Fibrillation in Patients With Diabetes?" Cardiovasc Diabetol 2020.
MLA引用形式Yurista, Salva R., et al. "Sodium-glucose Co-transporter 2 Inhibition As a Mitochondrial Therapy for Atrial Fibrillation in Patients With Diabetes?" Cardiovasc Diabetol 2020.
警告: この引用は必ずしも正確ではありません.